The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization

Technological advances in the management of diabetes, especially type 1 diabetes (T1D), have played a main role in significantly improving glycemic control of these patients in recent years. Undoubtedly, the most important advance has been the commercialization of hybrid closed-loop systems (HCL). T...

Descripción completa

Detalles Bibliográficos
Autores: Chico A, Moreno-Fernández J, Fernández-García D, Solá E
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p15752
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/15752
Access Level:acceso abierto
Palabra clave:Artificial pancreas
Automated insulin delivery
Continuous glucose monitoring
Hybrid closed-loop system
Insulin pump
Multiple daily injections
Time in range
Type 1 diabetes
Control-IQ technology
id ES_7b871530ca0eb8aee876d3bc4679a665
oai_identifier_str oai:fisabio.fundanetsuite.com:p15752
network_acronym_str ES
network_name_str España
repository_id_str
spelling The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and OptimizationChico AMoreno-Fernández JFernández-García DSolá EArtificial pancreasAutomated insulin deliveryContinuous glucose monitoringHybrid closed-loop systemInsulin pumpMultiple daily injectionsTime in rangeType 1 diabetesControl-IQ technologyTechnological advances in the management of diabetes, especially type 1 diabetes (T1D), have played a main role in significantly improving glycemic control of these patients in recent years. Undoubtedly, the most important advance has been the commercialization of hybrid closed-loop systems (HCL). Their effectiveness places them in the different guidelines from scientific societies as the gold standard for the treatment of people with T1D. However, obtaining the maximum performance from these systems requires a degree of expertise from the professionals who care for these patients. Specifically, the Tandem X2:slim with Control-IQ technology system, due to its features and configuration options and adjustments, allows T1D patients to better adapt the management of diabetes to multiple circumstances in their day-to-day life. It is necessary, however, to follow a systematic process to start the system and also for the subsequent follow-up, which allows its optimization in the shortest possible time. This expert recommendation reviews the main features of this HCL system, suggesting how to implement it and optimize its use after gaining experience treating many patients.SPRINGER HEIDELBERG2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/15752Diabetes TherapyISSN: 18696953ISSNe: 18696961reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p157522026-06-11T12:45:17Z
dc.title.none.fl_str_mv The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
title The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
spellingShingle The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
Chico A
Artificial pancreas
Automated insulin delivery
Continuous glucose monitoring
Hybrid closed-loop system
Insulin pump
Multiple daily injections
Time in range
Type 1 diabetes
Control-IQ technology
title_short The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
title_full The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
title_fullStr The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
title_full_unstemmed The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
title_sort The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization
dc.creator.none.fl_str_mv Chico A
Moreno-Fernández J
Fernández-García D
Solá E
author Chico A
author_facet Chico A
Moreno-Fernández J
Fernández-García D
Solá E
author_role author
author2 Moreno-Fernández J
Fernández-García D
Solá E
author2_role author
author
author
dc.subject.none.fl_str_mv Artificial pancreas
Automated insulin delivery
Continuous glucose monitoring
Hybrid closed-loop system
Insulin pump
Multiple daily injections
Time in range
Type 1 diabetes
Control-IQ technology
topic Artificial pancreas
Automated insulin delivery
Continuous glucose monitoring
Hybrid closed-loop system
Insulin pump
Multiple daily injections
Time in range
Type 1 diabetes
Control-IQ technology
description Technological advances in the management of diabetes, especially type 1 diabetes (T1D), have played a main role in significantly improving glycemic control of these patients in recent years. Undoubtedly, the most important advance has been the commercialization of hybrid closed-loop systems (HCL). Their effectiveness places them in the different guidelines from scientific societies as the gold standard for the treatment of people with T1D. However, obtaining the maximum performance from these systems requires a degree of expertise from the professionals who care for these patients. Specifically, the Tandem X2:slim with Control-IQ technology system, due to its features and configuration options and adjustments, allows T1D patients to better adapt the management of diabetes to multiple circumstances in their day-to-day life. It is necessary, however, to follow a systematic process to start the system and also for the subsequent follow-up, which allows its optimization in the shortest possible time. This expert recommendation reviews the main features of this HCL system, suggesting how to implement it and optimize its use after gaining experience treating many patients.
publishDate 2024
dc.date.none.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/15752
url https://fisabio.portalinvestigacion.com/publicaciones/15752
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SPRINGER HEIDELBERG
publisher.none.fl_str_mv SPRINGER HEIDELBERG
dc.source.none.fl_str_mv Diabetes Therapy
ISSN: 18696953
ISSNe: 18696961
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411521610645504
score 15,812429

Similares en LA Referencia